IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GALLIA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.177
NA - Nord America 1.962
AS - Asia 1.670
SA - Sud America 160
AF - Africa 27
OC - Oceania 17
Totale 6.013
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.872
GB - Regno Unito 804
CN - Cina 536
SG - Singapore 504
IT - Italia 370
DE - Germania 230
RU - Federazione Russa 155
SE - Svezia 146
VN - Vietnam 138
FR - Francia 133
HK - Hong Kong 122
BR - Brasile 107
IN - India 85
JP - Giappone 63
CA - Canada 61
IE - Irlanda 56
KR - Corea 49
FI - Finlandia 48
TR - Turchia 48
BD - Bangladesh 44
NL - Olanda 41
ES - Italia 30
BE - Belgio 29
CH - Svizzera 28
PL - Polonia 27
ID - Indonesia 20
UA - Ucraina 20
AR - Argentina 18
CO - Colombia 17
DK - Danimarca 17
MX - Messico 17
AU - Australia 15
EU - Europa 14
ZA - Sudafrica 8
AT - Austria 7
IQ - Iraq 7
LU - Lussemburgo 7
MY - Malesia 7
PK - Pakistan 7
PT - Portogallo 6
TW - Taiwan 6
UZ - Uzbekistan 6
BO - Bolivia 5
EG - Egitto 5
IR - Iran 5
NO - Norvegia 5
CI - Costa d'Avorio 3
CL - Cile 3
EC - Ecuador 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
AZ - Azerbaigian 2
BB - Barbados 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
JO - Giordania 2
LT - Lituania 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BT - Bhutan 1
BZ - Belize 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GF - Guiana Francese 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
YE - Yemen 1
Totale 6.027
Salva come PNG Salva come JPEG
Città #
Southend 691
Singapore 275
Chandler 274
Ashburn 167
Milan 147
Hong Kong 120
Seattle 105
Beijing 100
Frankfurt am Main 97
Princeton 90
Santa Clara 74
Ann Arbor 65
Wilmington 61
Dublin 56
Council Bluffs 55
Los Angeles 50
New York 48
San Jose 47
Phoenix 44
Ho Chi Minh City 39
Toronto 36
Fairfield 35
Lauterbourg 35
Des Moines 33
Hanoi 32
Houston 32
Dallas 31
Moscow 30
Buffalo 29
Nanjing 29
Bengaluru 28
London 28
Jinan 27
Tokyo 27
Woodbridge 25
Redwood City 20
Rome 19
Sunnyvale 19
Mountain View 18
Warsaw 18
Brussels 16
Guangzhou 16
Redmond 16
Somerville 16
Shanghai 15
Boardman 14
Jakarta 14
Shenzhen 14
Dearborn 13
Hebei 13
Helsinki 12
San Genesio Ed Uniti 12
São Paulo 12
Philadelphia 11
Zurich 11
Cangzhou 10
Munich 10
Nanchang 10
Paris 10
Barcelona 9
Berlin 9
Bogotá 9
Columbus 9
Hangzhou 9
Manchester 9
Sakarya 9
Shenyang 9
Ulm 9
Andover 8
Haiphong 8
Madrid 8
Montreal 8
Odernheim 8
San Diego 8
Cambridge 7
Duncan 7
Naples 7
Ningbo 7
Roubaix 7
The Dalles 7
Tianjin 7
Waltham 7
Amsterdam 6
Da Nang 6
Lanzhou 6
Miami 6
Mumbai 6
Nuremberg 6
Salerno 6
San Francisco 6
Tashkent 6
Belo Horizonte 5
Bexley 5
Bitonto 5
Changsha 5
Chicago 5
Fuzhou 5
Grafing 5
Istanbul 5
Jacksonville 5
Totale 3.685
Salva come PNG Salva come JPEG
Nome #
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy 496
Home monitoring of maintenance intravenous immunoglobulin therapy in patients with chronic inflammatory neuropathy 356
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 346
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : a retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone 255
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? 219
A novel MAPT mutation associated to late-onset spinal muscular atrophy without dementia in a large Italian family 215
Unraveling gene expression profiles in peripheral motor nerve from Amyotrophic Lateral Sclerosis patients : insights into pathogenesis 200
Anti-sulfatide IgM antibodies in peripheral neuropathy : to test or not to test? 184
Cryptogenetic chronic sensory neuropathy: a retrospective study 167
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation 163
Efficacy and tolerability of different brandof IVIg in the maintenance treatment of chronic immune mediated neuropathy 155
Defining the peripheral nerve enviroment in amyotrophic lateral sclerosis and motor neuropathies: morphological and WG expression studies in human motor nerve biopsies 153
Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy 148
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 148
Multifocal Motor Neuropathy 146
Anti-sulfatide IgM antibodies in peripheral neuropathy : to test or not to test? 140
Chronic inflammatory demyelinating polyradiculoneuropathy and related neuropathies 138
Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update 136
Expanding the spectrum of lower motor neuron sindrome: chronic motor axonal neuropathy 131
Cryptogenetic chronic sensory neuropathy: a retrospective study on 91 patients 129
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic criteria, clinal variants and response to therapy 128
Chronic inflammatory demyelinating polyradiculoneuropathy : diagnostic criteria, clinal variants and response to therapy 127
Anti-sulfatide IgM antibodies in peripheral neuropathy : to test or not to test? 127
Does ability to walk reflect general functionality in inflammatory neuropathies? 127
Frequency and time to relapse after discontinuing 6-month therapy with intravenous Immunoglobulin or methylprednisolone in chronic inflammatory demyelinating polyradiculoneuropathy 124
Frequency and time to relapse after therapy discontinuation in CIDP patients treated for six months with IVIg or IV Methylprednisolone (IMC follow-up study) 122
Quality of life in inflammatory neuropathies : the IN-QoL 122
Diagnosis and treatment of chronic immune mediated neuropathies 121
A prospective open-label trial with lenalinomide in POEMS syndrome 119
High-dose immunoglobulin pulse therapy and risk of Covid19 infection 118
Efficacy and tolerability of different brandof IVIg in the maintenance treatment of chronic immune mediated neuropathy 115
Lumbar root neurinoma as a possible cause of meralgia paresthetica 112
High-dose intravenous steroids in definite or suspected immune mediated neuropathies 109
Multifocal Motor Neuropathy : Current Therapies and Novel Strategies 109
Chronic inflammatory demyelinating polyradiculoneuropathy: clinal variants and comparison of diagnostic criteria 108
High dose intravenous steroid therapy in patients with idiopathic neuropathy and suspected immunological involvement 103
Frequency and time to relapse after discontinuation of six months therapy with IVIg or IV Methylprednisolone in patients with CIDP (IMC follow-up study) 101
A prospective open-label trial with lenalinomide in POEMS syndrome : preliminary results 99
Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update: Erratum 93
Randomized controlled trial of intravenous immunoglobulins versus Intravenous methylprednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (IMC study) 87
A randomized, double blind, controlled trial of Intravenous immunoglobulins versus intravenous methylprednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (IMC study) 78
Totale 6.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 0 0 0 0 0 97 21
2021/2022564 23 28 32 23 95 20 28 28 62 72 21 132
2022/2023750 85 97 79 85 57 114 15 35 125 17 28 13
2023/2024415 12 31 37 30 92 32 20 21 18 21 57 44
2024/20251.048 33 77 32 124 124 53 23 104 83 67 87 241
2025/20261.640 212 119 118 124 259 135 203 81 116 127 146 0
Totale 6.374